To investigate the possible involvement of antigen-processing genes in the pathogenesis of psoriasis, we analyzed the polymorphisms of the TAP1, TAP2, LMP2, LMP7, DMA, and DMB genes in 98 Korean psoriasis patients and compared them with 184 healthy controls. The frequencies of TAP2 n B/B [relative risk (RR) ¼ 3.6, po0.0002] and TAP2 n B (RR ¼ 1.7, po0.05) were signi¢cantly increased, but TAP1 n B (RR ¼ 0.3, po0.002) and TAP2 n A (RR ¼ 0.6, po0.03) were signi¢cantly decreased, in the patients compared to the controls. We performed further analysis on the TAP1 and TAP2 single nucleotide polymorphisms and found signi¢cant di¡erences between the patients and controls in TAP1 single nucleotide polymorphism at position 637 and in TAP2 at 665. In HLA-DM, DMA n 0102 (RR ¼ 2.5, po0.0003) was signi¢cantly increased, but DMA n 0101/ 0101 (RR ¼ 0.4, po0.0004) and DMB n 0103/0103 (RR ¼ 0.3, po0.005) were signi¢cantly decreased in the patients compared to the controls. The TAP and HLA-DM alleles were also analyzed according to the age of onset of psoriasis in the patients (types I and II). It was found that the HLA-DM alleles showed a greater association in type I than type II patients. An analysis of the linkage disequilibrium and strati¢cation also indicated that the alleles of TAP and HLA-DM might be independently associated with HLA-Cw n 0602 in psoriasis patients. The strati¢cation analysis between DMA n 0101/0101 and DMB n 0103/0103 showed that a certain factor, controlled by a gene located between DMA and DMB, might provide strong protection against psoriasis, independently of Cw n 0602, in our Korean population. In conclusion, our data suggest that the TAP and HLA-DM alleles could lead to genetic susceptibility toward psoriasis in Koreans.
To investigate the possible involvement of antigen-processing genes in the pathogenesis of psoriasis, we analyzed the polymorphisms of the TAP1, TAP2, LMP2, LMP7, DMA, and DMB genes in 98 Korean psoriasis patients and compared them with 184 healthy controls. The frequencies of TAP2 n B/B [relative risk (RR) ¼ 3.6, po0.0002] and TAP2 n B (RR ¼ 1.7, po0.05) were signi¢cantly increased, but TAP1 n B (RR ¼ 0.3, po0.002) and TAP2 n A (RR ¼ 0.6, po0.03) were signi¢cantly decreased, in the patients compared to the controls. We performed further analysis on the TAP1 and TAP2 single nucleotide polymorphisms and found signi¢cant di¡erences between the patients and controls in TAP1 single nucleotide polymorphism at position 637 and in TAP2 at 665. In HLA-DM, DMA n 0102 (RR ¼ 2.5, po0.0003) was signi¢cantly increased, but DMA n 0101/ 0101 (RR ¼ 0.4, po0.0004) and DMB n 0103/0103 (RR ¼ 0.3, po0.005) were signi¢cantly decreased in the patients compared to the controls. The TAP and HLA-DM alleles were also analyzed according to the age of onset of psoriasis in the patients (types I and II). It was found that the HLA-DM alleles showed a greater association in type I than type II patients. An analysis of the linkage disequilibrium and strati¢cation also indicated that the alleles of TAP and HLA-DM might be independently associated with HLA-Cw n 0602 in psoriasis patients. The strati¢cation analysis between DMA n 0101/0101 and DMB n 0103/0103 showed that a certain factor, controlled by a gene located between DMA and DMB, might provide strong protection against psoriasis, independently of Cw n 0602, in our Korean population. In conclusion, our data suggest that the TAP and HLA-DM alleles could lead to genetic susceptibility toward psoriasis in Koreans. Key words: psoriasis/HLA-DM/LMP/TAP. J Invest Dermatol 120: 616^622, 2003 P soriasis lesions are characterized by epidermal hyperplasia and the presence of acute and chronic in£ammatory cells. Activated lymphocytes, other immune accessory cells, and lymphokines have also been detected in psoriasis plaques (Elder et al, 1994; Henseler, 1998) . It has been estimated that in most countries 1%^3% of the population are a¡ected by psoriasis (Ikaheimo et al, 1996) . Psoriasis is believed to be a multigene disease, the expression of which is partially dependent on external factors (Traupe, 1995) . HLA-Cw6 shows the most pronounced increase without regard to race or ethnicity, supporting the presence of genes within the major histocompatibility complex (MHC) to be the most important genetic factors for determining susceptibility to psoriasis (Tiilikainen et al, 1980) . Recently, genome-wide scans have provided evidence suggesting a linkage between psoriasis and the HLA and several non-HLA loci. Of these, the HLA-linked locus (PSORS1) has been suggested as the major locus for the susceptibility to psoriasis (Trembath et al, 1997; Veal et al, 2001 ). PSORS1 contains ¢ve known genes, three predicted transcripts, and a number of expressed sequence tags (Oka et al, 1999) . These genes have been analyzed, and signi¢cant associations have been detected for the nonconservative coding polymorphisms within the corneodesmosin (CDSN) and HCR. Several studies have reported a signi¢cant association for a coding single nucleotide polymorphism (SNP) in the CDSN gene (Allen et al, 1999; Jenisch et al, 1999; Tazi Ahnini et al, 1999) , but this association was not observed in certain ethnic groups, including the Japanese and Finnish (Ishihara et al, 1996; Enerback et al, 2000) . Asumalahti et al have demonstrated the HCR gene to be ubiquitously expressed but upregulated in psoriatic epidermis, with a signi¢cant association between psoriasis and the HCR alleles (Asumalahti et al, 2000) . Other studies have suggested that this association of the HCR with psoriasis was solely due to the linkage disequilibria (LD) with Cw n 0602 and had no pathologic relevance (O'Brien et al, 2001) . Therefore, it is still unclear if these genes, or regions, are directly involved in the predisposition to psoriasis, or if they are closely linked to other disease-related genes, forming part of a larger disease-associated haplotype.
In addition to HLA genes, immune responses are dependent on several genes encoding molecules that generate and translocate antigenic peptides. The genes involved in the class I and II antigen processing pathways possess TAP, LMP, and HLA-DM, and may be considered as candidate genes for the susceptibility to psoriasis. The TAP genes are located in the HLA class II region, between the DQB1 and DPA1 loci, and exhibit genetic polymorphisms. The TAP genes consist of the TAP1 and TAP2 genes, which encode a heterodimer molecule that forms a heterodimeric complex for delivering antigenic peptides to the endoplasmic reticulum prior to the assembly of class I molecules (Deverson et al, 1990; Spies et al, 1990; Trowsdale et al, 1990) . Two polymorphic sites have been found in the TAP1 gene, and four in the TAP2. With the TAP1 and TAP2 there are four and eight possible allele combinations of polymorphisms, respectively, at these sites (Powis et al, 1993) . The LMP2 and LMP7 genes are located within the class II region, and encode two subunits of the proteasome complex involved in the degradation of cytosolic proteins and the generation of antigenic peptides (Brown et al, 1991; Ortiz-Navarrete et al, 1991) . Although the LMP proteolytic enzymes may not be essential for the processing of peptides bound by MHC class I molecules (Arnold et al, 1992) , they may amplify speci¢c endopeptidase activities of the proteasome, generating peptides suitable for MHC class I molecules. The HLA-DM genes catalyze peptide loading into the HLA class II molecules (Kelly et al, 1991a) , are located in the HLA class II region, between the DQB1 and DPB1 loci, and exhibit genetic polymorphisms (Carrington et al, 1993b; Carrington and Harding, 1994) . The HLA-DM gene polymorphisms may in£uence peptide loading on the HLA class II molecules. Thus, the TAP, LMP, and HLA-DM may play a restrictive role in antigen processing and presentation, and so are attractive candidates as additive susceptibility factors toward psoriasis. In this study, we examined the polymorphisms of the TAP1, TAP2, LMP2, LMP7, HLA-DMA, and HLA-DMB genes, and their association with psoriasis, in a population of Korean patients.
MATERIALS AND METHODS

Subjects
The study population comprised of 96 Korean psoriasis patients, 44 females and 52 males, with an age range from 12 to 83 y. The patients were divided into two groups based on their age at the onset of psoriasis; type I (n ¼ 73), below 30 y and II (n ¼ 23), above 30 y (Kim et al, 2000) . The average age at onset of psoriasis was 23.4 y. Their results were compared with 184 controls without psoriasis. All the subjects gave their formal agreement for a genomic study and Ethical approval was obtained from The Catholic university of Korea's Human Research Ethics Committee.
TAP gene polymorphisms
The TAP alleles were determined by the polymerase chain reaction (PCR) single-strand conformation polymorphism (SSCP) and PCR ampli¢cation refractory modi¢cation system (ARMS) methods as previously reported (Powis et al, 1993) .
PCR-SSCP analysis of TAP1 at codons 333 and 637, and TAP2 at codons 379 and 665 The PCR were carried out with primers in a volume of 10 ml with 10 Â bu¡er (500 mM KCl, 100 mM Tris^HCl pH 8.3 and 15 mM MgCl 2 ); 1 pM of each oligonucleotide primer; dNTP (200 mM each of dATP, dGTP, and dTTP, and 100 mM of dCTP); 5 mCi [a-32 P]dCTP; 100 ng of genomic DNA; and 0.5 U Taq DNA polymerase (5 U per ml; Boehringer Mannheim, Mannheim, Germany). The PCR were carried out in a Perkin Elmer 9600 thermocycler (PE Biosystems, Foster City, CA) under the following conditions: 5 min at 951C; 35 cycles of 30 s at 951C (denaturation), 30 s at 621C (annealing), and 40 s at 721C (elongation); and ¢nally 10 min at 721C. The PCR products were mixed with a solution of 10 mM NaOH, 95% formamide, 0.05% bromophenol, and 0.05% xylene cyanol and denatured at 951C for 2^3 min. The products were separated on a 6% nondenaturing acrylamide gel for 4 h at 41C and 50 W. For the autoradiography, the gels were ¢xed, dried, and exposed for 2^18 h using an X-ray ¢lm atÀ701C and an intensifying screen.
PCR-ARMS analysis forTAP2 gene polymorphism at codon 565 DNA samples (100 mg per ml) were ampli¢ed in reaction mixtures containing Taq DNA polymerase (Boehringer Mannheim), 10 Â bu¡er, primers, 200 mM dNTPs, and distilled water. The PCR was carried out in a Perkin Elmer 9600 thermocycler (PE Biosystems) under the following conditions: 5 min at 951C; 35 cycles of 1 min at 951C (denaturation), 1 min at 621C (annealing), and 1 min at 721C (elongation); and ¢nally 10 min at 721C. The ampli¢ed PCR products were separated on a 1.5% agarose gel and stained with ethidium bromide.
Allelic assignments forTAP1 and TAP2 The amino acids at the polymorphic positions 333 and 637 in the TAP1 gene, and 379, 565, and 665 in the TAP2 gene, were analyzed. Each position is an SNP: TAP1 333 (A-G, Ile-Val) and TAP1 637 (A-G, Asp-Gly); and TAP2 379 (G-A, Val-Ile), TAP2 565 (G-A, Ala-Thr), and TAP2 665 (A-G, Thr-Ala). Each allele of the TAP1 and TAP2 genes was de¢ned by the combination of polymorphisms at di¡erent positions, as follows: TAP1 n A (Ile-333 and Asp-637), TAP1 n B (Val-333 and Gly-637), and TAP1 n C (Val-333 and Asp-637); and TAP2 n A (Val-379, Ala-565, and Thr-665), TAP2 n B (Val-379, Ala-565, and Ala-665), TAP2 n C (Ile-379, Ala-565, and Thr-665), TAP2 n D (Ile-379, Thr-565, and Thr-665), TAP2 n E (Val-379, Thr-565, and Thr-665), and TAP2 n G (Ile-379, Ala-565, and Ala-665).
LMP gene polymorphisms
The genotyping of the LMP2 and LMP7 were carried out by PCR restriction fragment length polymorphism as previously described (Kelly et al, 1991b) . The polymorphic positions at nucleotides 3911, 3912, and 4069 in the LMP7 gene, and at the amino acid position 60 in the LMP2 gene, were analyzed [LMP7 3911 (T-G), LMP7 3912 (C-T), and LMP7 4069 (C-T); and LMP2 60 (G-A, Arg-His)]. The LMP7 alleles were de¢ned by the combination of polymorphisms at di¡erent positions, as follows: LMP7 n A (T-3911, C-3912, and C-4069), LMP7B n (G-3911, C-3912, and C-4069), LMP7 n C (C-3911, C-3912, and T-4069), and LMP7 n D (G-3911, T-3912, and T-4069). LMP2 alleles were assigned as LMP2 n R (Arg) and LMP2 n H (His). The PCR were carried out with primers in a volume of 20 ml with 10 Â bu¡er; 1 pM of each oligonucleotide primer; 200 mM dNTPs; 100 ng of genomic DNA; and 0.5 U Taq DNA polymerase (Boehringer Mannheim). The PCR were carried out in a Perkin Elmer 9600 thermocycler (PE Biosystems) under the following conditions: (i) LMP2, 5 min at 951C and 35 cycles of 15 s at 951C (denaturation), 40 s at 671C (annealing), 30 s at 721C (elongation), and ¢nally 10 min at 721C; and (ii) LMP7, 5 min at 951C and 35 cycles of 7 s at 951C (denaturation), 30 s at 621C (annealing), 30 s at 721C (elongation), and ¢nally 10 min at 721C. The ampli¢ed PCR products were subjected to digestion with a restriction endonuclease, Hha I (USB, Cleveland, OH), at 371C for 1 h. After digestion, the LMP2 fragments were fractionated on an 8% acrylamide gel at 300 V for 2.5 h, and the LMP7 fragments on a 2% agarose gel at 200 V for 30 min, and were visualized by staining with ethidium bromide.
HLA-DM gene polymorphisms
The genotyping of the HLA-DMA and HLA-DMB was carried out by PCR-SSCP, as previously described (Carrington et al, 1993b, Carrington and Harding, 1994) . Based on sequences from the third exon, four alleles of the DMA (DMA n 0101, n 0102, n 0103, and n 0104) and ¢ve of the DMB (DMB n 0101, n 0102, n 0103, n 0104, and n 0105) were analyzed. These nucleotide positions involved codons 140, 155, and 184 in the DMA and codons 144 and 179 in the DMB, which all result in nonsynonymous amino acid changes: DMA 140 (G-A, Val-Ile), DMA 155 (G-C, Gly-Ala), DMA 184^1 (C-T, Val-Ile), and DMA 184^2 (G-A, Arg-His); DMB 144 (C-A, Ala-Glu; C-T, Ala-Val) and DMB 179 (T-C, Ile-Thr). Each DMA and DMB allele was assigned by the combination of polymorphisms at di¡erent positions as follows: DMA n 0101 (Val-140, Gly-155, and Arg-184), DMA n 0102 (Ile-140, Gly-155, and Arg-184), DMA n 0103 (Val-140, Ala-155, and His-184), and DMA n 0104 (Ile-140, Gly-155, and Cys-184); DMB n 0101 (Ala-144 and Ile-179), DMB n 0102 (Glu-144 and Ile-179), DMB n 0103 (Ala-144 and Thr-179), DMB n 0104 (Val-144 and Thr-179), and DMB n 0105 (Val-144 and Ile-179). The PCR were carried out with primers in 10 ml with 10 Â bu¡er; 1 pM of each oligonucleotide primer; dNTP (200 mM each of dATP, dGTP, and dTTP, and 100 mM dCTP); 5 mCi [a-32 P]dCTP; 100 ng of genomic DNA; and 0.5 U Taq DNA polymerase (Boehringer Mannheim). The PCR were carried out in a Perkin Elmer 9600 thermocycler (PE Biosystems) under the following conditions: 5 min at 951C; 30 cycles of 30 s at 951C (denaturation), 60 s at 651C (annealing), and 90 s at 721C (elongation); and ¢nally 10 min at 721C. The PCR products were mixed with a solution containing 10 mM NaOH, 95% formamide, 0.05% bromophenol, and 0.05% xylene cyanol, and denatured at 951C for 2^3 min. The products were separated on a 6% nondenaturing acrylamide gel for 4 h, at 41C and 50 W. For the autoradiography, the gels were ¢xed, dried, and exposed for 2^18 h using an X-ray ¢lm at^701C and an intensifying screen.
HLA-C genotyping The HLA-C typing was performed using PCR-ARMS by the previously described method (Bunce and Welsh, 1994) . Each tube contained a primer mix consisting of the allele-or group-speci¢c primer pairs, with a positive control primer matched to the nonallelic sequences. The HLA-C typing included 23 sets of primer mixtures. The PCR were performed in 7 ml, modi¢ed from the Twelfth International Histocompatibility Workshop reference manual for class I ARMS-PCR. The sizes of the PCR products were de¢ned on 1.5% agarose gel, prestained with ethidium bromide.
Statistics The odds ratios (OR) were calculated using Woolf 's formula (Haldane, 1955) and by convention, and were expressed as the relative risk (RR). Haldane's modi¢cation of the formula was used when one element of the equation was zero. Any statistically signi¢cant di¡erence was tested by w 2 analysis with 1 degree of freedom or by a two-tailed Fisher's exact test when the criteria for the w 2 analysis were not ful¢lled. A p-value of less than 0.05 was considered statistically signi¢cant. Delta values for the LD and haplotype frequency (HF) were calculated by the formula of Mattiuz et al (1970) . An exact test (Guo and Thompson, 1992) was employed to evaluate deviations from the expected Hardy^Weinberg genotypic proportions, using the Arlequin computer program package .
RESULTS
Frequencies of TAP1, TAP2, LMP2, LMP7, DMA, and DMB alleles We tested the Hardy^Weinberg equilibria of all genes studied in the control group with the exception of the TAP2, as not all heterozygotes can be discriminated using our typing system. The genotype distributions were consistent with the assumption of the Hardy^Weinberg equilibrium, with the possible exception of the LMP7, due to an excess of homozygotes (the observed and expected frequencies were 50.5% and 60.3%, respectively).
The frequencies of the TAP1 and TAP2 alleles for the patients and controls are shown in Table I . The frequencies of TAP2 n B/B (RR ¼ 3.6, po0.0002) and TAP2 n B (RR ¼ 1.7, po0.05) were signi¢cantly increased, but those of TAP1 n A/B (RR ¼ 0.4, po0.02), TAP1 n B (RR ¼ 0.3, po0.002), and TAP2 n A (RR ¼ 0.6, po0.03), were signi¢cantly decreased, in the patients compared to the controls. To exclude the unclear assignment of some alleles due to heterozygosity at more than one residue, we also analyzed individual TAP SNPs. There were signi¢cant di¡erences in the frequencies of the TAP1 SNP at the 637 position and the TAP2 at the 665 position between the patients and controls (Table I) . At the TAP1-637 residue, the genotype frequency of Asp-637/Asp-637 homozygote (RR ¼ 2.6, po0.003) and the gene frequency of Asp-637 (RR ¼ 2.5, po0.002) were signi¢cantly increased in the patients compared to the controls. The phenotype and gene frequencies of Gly-637 position were signi¢cantly decreased in the patients compared to the controls. At the TAP2-665 position, the frequencies of Ala-665/Ala-665 (RR ¼ 3.4, po0.003), Ala-665 phenotype (RR ¼ 2.0, po0.02), and Ala-665 gene (RR ¼ 1.9, po0.0004) were signi¢cantly increased, but Thr-665/Thr-665 (RR ¼ 0.5, po0.02), Thr-665 phenotype (RR ¼ 0.3, po0.0002), and Thr-665 gene (RR ¼ 0.5, po0.0004) were signi¢cantly decreased in the patients compared to the controls. There were no signi¢cant di¡erences in the TAP1-333, TAP2-379, and TAP2-565 SNPs between the patients and controls (data not shown). Table II shows the frequencies of the HLA-DM alleles in the patients and controls. The frequencies of DMA n 0101/0102 (RR ¼ 2.0, po0.006) and DMA n 0102 (RR ¼ 2.5, po0.0003) were signi¢cantly increased, but DMA n 0101/0101 (RR ¼ 0.4, po0.0004) and DMB n 0103/0103 (RR ¼ 0.3, po0.005) were signi¢cantly decreased, in the patients compared to the controls. The frequencies of the LMP2 and LMP7 in the patients and controls were studied, but no signi¢cant di¡erences were found (data not shown).
Distribution of TAP, LMP, and HLA-DM alleles according to age of onset We previously mentioned that types I and II psoriasis were divided according to the age at onset of psoriasis, i.e., below or above 30 y, respectively, in our Korean population (Kim et al, 2000) . We analyzed the frequencies of TAP and HLA-DM alleles for type I and II psoriasis patients ( Table III) . The frequencies of TAP2 n B/B and DMA n 0102 were signi¢cantly increased in type I patients compared to the controls, but there were no signi¢cant di¡erences of these two alleles between types I and II patients, although the frequency of DMA n 0102 was relatively increased in type I compared to type II patients. X, A/G, B/C, B/D, E/G, A/D, or C/E (TAP2 n A/TAP2 n G and TAP2 n B/TAP2 n C, TAP2 n B/TAP2 n D and TAP2 n E/TAP2 n G, TAP2 n A/TAP2 n D and TAP2 n C/TAP2 n E heterozygotes cannot be distinguished by the typing system that we designed.) There were also signi¢cant di¡erences of TAP1 n B, DMA n 0101/ 0101, and DMB n 0103/0103 between the type I patients and controls. The HLA-DM alleles showed a greater decrease in type I patients than type II, although this was not statistically signi¢cant.
LD and HF between the TAP1, TAP2, DMA, and DMB alleles Table IV shows the two-loci haplotypes of the TAP1, TAP2, DMA, and DMB to have signi¢cant (po0.05) positive LD and frequencies of more than 5% in the psoriasis patients. We found a number of signi¢cant (both positive and negative) LD among these alleles, which were present to di¡erent extents in the patients compared with the controls, but these linked alleles only showed a low LD when compared to the HF. These results show the possibility that the region between the TAP and HLA-DM may have a comparatively high recombination rate in our population, as shown by other populations (van Endert et al, 1992; Carrington et al, 1993a) .
Association of the TAP1, TAP2, DMA, and DMB with CW n 0602 We previously reported that HLA-Cw n 0602 was strongly associated with psoriasis in Koreans (Kim et al, 2000) . In this study, we also found that the frequency of Cw n 0602 was signi¢cantly increased in psoriasis patients compared to controls (psoriasis patients versus normal controls 75.0% vs 6.5%, RR ¼ 43.0, po2 Â 10^3 2 ). To determine if the observed associations of the TAP1, TAP2, DMA, and DMB with psoriasis were disease related or the consequence of an LD with Cw n 0602, we analyzed the LD and performed strati¢cation analysis between the associated alleles and Cw n 0602 in the patients and controls. No signi¢cantly positive and negative disequilibria were observed between the alleles and Cw n 0602 in either the patients or controls ( Table V) . The results of the strati¢cation analysis are shown in Table VI (Svejgaard and Ryder, 1994) . Cw n 0602 and the associated alleles of TAP1, TAP2, DMA, and DMB were signi¢cantly associated with psoriasis in the test of individual association [1] . Strati¢cation of Cw n 0602 showed that TAP2 n B/B was signi¢cantly increased in the Cw n 0602-negative group, and TAP1 n B and DMB n 0103/0103 were signi¢cantly decreased in the Cw n 0602-positive group [2]. Cw n 0602 was signi¢cantly increased in the patients compared to the controls, irrespective of the positivity or negativity for the associated alleles of TAP1, TAP2, DMA, and DMB [3]. There were signi¢cant di¡erences in associations between the associated alleles and Cw n 0602 for patients with psoriasis in an investigation of whether the associations between Cw n 0602 and the associated alleles di¡er [4] . TAP2 n B/B and DMA n 0102 alleles considerably increased the OR value of Cw n 0602, but TAP1 n B, DMA n 0101/0101, and DMB n 0103/0103 alleles decreased that of Cw n 0602 in the test of a combined association [5] . Taken together with the LD data and the strati¢ed analysis, these results showed that TAP1, TAP2, DMA, and DMB alleles might be independently associated with Cw n 0602 in psoriasis patients, although Cw n 0602 was more strongly associated with psoriasis than the other alleles.
Combined analysis of DMA n 0101/0101 and DMB n 0103/ 0103 We investigated the relation of DMA n 0101/0101 and DMB n 0103/0103 alleles in psoriasis because the two alleles showed a signi¢cant association and LD in the patients (Table  VII) . DMA n 0101/0101 and DMB n 0103/0103 were negatively associated with psoriasis in a test of individual association [1]. DMA n 0101/0101 only showed a signi¢cant decrease in DMB n 0103/0103 -negative groups but DMB n 0103/0103 was insigni¢cantly decreased in both DMA n 0101/0101-positive and DMA n 0101/0101-negative groups in strati¢cation of the two alleles [2, 3]. There were no signi¢cant di¡erences between the two associations in a test of di¡erence between the two alleles' association [4] . A signi¢cant combined association between the two genotypes was shown [5], and there was a signi¢cant association between the two genotypes in both the patients and controls [6] . These results proved that DMA n 0101/0101 and DMB n 0103/0103 might interact with each other, indicating a certain stronger negative factor. We performed further analysis on the haplotype of DMA n 0101/0101^DMB n 0103/0103 and Cw n 0602, which all showed signi¢cant decreases in the psoriasis patients [1] . The haplotype was signi¢cantly decreased in the Cw n 0602-positive group but not in the Cw n 0602-negative group [2] . When Cw n 0602 was strati¢ed for the presence or absence of the haplotype, it was signi¢cantly increased in both the haplotype-positive and haplotype-negative groups [3] . There was a signi¢cant di¡erence between the two factors' associations
TableV. Analysis of linkage disequilibrium between the associated alleles and HLA-Cw n 0602 in psoriasis patients and normal controls TableVII. Strati¢cation analysis between DMA n 0101/0101 and DMB n 0103/0103 and between the haplotype of DMA n 0101/ 0101ÀDMB n 0103/0103 and HLA-Cw n 0602 A and B (patients, linkage between A and B in patients; controls, linkage between A and B in patients) .
OR values indicate that the corresponding p-values are signi¢cant (po0.05).
[4]. The haplotype considerably decreased the OR value of Cw n 0602 with the combined association [5] . There was no signi¢cant association between the haplotype and Cw n 0602 in either the psoriasis patients or controls [6] . These results therefore indicate that some factor, controlled by a gene located between DMA and DMB, might be associated with a strong protection against psoriasis, independently of Cw n 0602 association.
DISCUSSION
The TAP genes are polymorphic, and due to their essential involvement in class I antigen presentation might represent additional susceptibility genes to disease. The functional consequences of TAP polymorphisms are unknown. TAP molecules are required not only for peptide transport, however, but also for the assembly of class I heavy chain a 2 -microglobulin dimers and the previously designed TAP-associated protein tapasin (Ortmann et al, 1997) . This interaction may be a target for consideration in the mechanism where a TAP polymorphism is involved in the pathogenesis of the disease. There have been several reports on the analysis of TAP alleles in patients with psoriasis. Fakler et al (1994) analyzed the TAP2 gene polymorphism in psoriasis, and showed no significant association between the alleles and psoriasis. Saeki et al (1998) showed a decrease in TAP2 n E allele in a Japanese population of psoriasis patients. Hohler et al (1996) reported an increase in TAP1 n A allele in patients with early onset of psoriasis. We found that the frequencies of TAP2 n B and TAP2 n B/B were sig-ni¢cantly increased and TAP1 n B and TAP2 n A were decreased in psoriasis patients compared with the controls (Table I) . We performed further analysis on the TAP1 and TAP2 SNPs and found signi¢cant di¡erences in the frequencies of the TAP1 SNP at the 637 position and the TAP2 at the 665 position between the patients and the controls ( Table I ). In the TAP1 at residue 637, the gene frequency of Asp-637 was signi¢cantly increased but Gly-637 was decreased in the patients compared to the controls. In the TAP2 at residue 665, Ala-665 was signi¢cantly increased but Thr-665 was decreased in the patients compared to the controls. There was also a signi¢cant LD between TAP1 n A and TAP2 n B (Table IV) and between TAP1 Asp-637 and the TAP2 Ala-665 (LD ¼ 3.8, po0.0001) in the patients compared to the controls. Quadri and Singal (1998) indicated that TAP1 n A and TAP1 n C alleles might favor the e⁄cient transport of peptides with a basic C-terminus, whereas TAP1 n B allele might translocate peptides regardless of the di¡erences in the C-terminal amino acid residue. This is due to the acidic nature of Asp residue present at the amino acid position 637 of TAP1 n A and TAP1 n C alleles, in contrast to Gly in TAP1 n B allele (Powis et al, 1993) . The major contact site(s) in the TAP1 might be located in the extreme transmembrane and cytoplasmic domains, close to the ATP binding site , which is the region where the human TAP1 shows polymorphism (Powis et al, 1992) . The TAP1 allele (TAP1 n A or TAP1 n C) containing the Asp residue at the 637 position, close to the peptide binding site, might in£uence the peptide^TAP1 interaction and their eventual transport to the ER endoplasmic reticulum (Quadri and Singal, 1998) . Asahina et al reported that the Asp at residue 9 and Ala at residue 73, on HLA-C molecules, were strongly associated in Japanese psoriasis patients (Asahina et al, 1991; . These residues might contribute to the formation of a peptide-binding pocket in HLA-C molecules, especially Cw n 0602 (Kostyu et al, 1997) . Although TAP2 alleles have been shown not to a¡ect peptide transport, a commonly coexpressed product of alternative splicing of the human TAP2 transcript, differing in the C-terminal region of the protein, exhibits distinct peptide selectivity (Yan et al, 1999) . A single point mutation, generated by site-directed mutagenesis in the human TAP2, has been shown su⁄cient to a¡ect the peptide transport speci¢city . Neisig et al (1998) have shown some HLA-C molecules to be more selective in their peptide binding than the HLA-A and HLA-B molecules, resulting in prolonged association with TAP, and a reduced formation of intracellular HLA-C^peptide complexes. Binding of HLA class I and speci¢c inhibitory natural killer (NK) receptors generates dominant inhibitory signals that neutralize any positive signals in NK cells; thus the self class I protects healthy cells from lysis by the NK. If this does not happen, the NK cells trigger cytotoxicity. It has been suggested that psoriasis may be triggered by the direct activation of CD8 and/or NK T cells bearing receptors for MHC class I molecules (Bos and De Rie, 1999) . Therefore it could be thought that the interaction of speci¢c TAP molecules and peptides might cause altered activity of speci¢c HLA-C, such as low expression on the cell surface, resulting in the activation of NK cell cytotoxicity to self cells in psoriasis patients, and the associated TAP alleles in this study might play a role in the development of psoriasis.
HLA-DM polymorphisms have been investigated in several autoimmune diseases but the role of HLA-DM polymorphisms in autoimmune diseases is not understood yet. Pinet et al (1997) observed an increase in both DMB n 0104 and DMA n 0103 phenotypes in rheumatoid arthritis. The homozygous DMB n 0101/0101 was reported to be positively associated with rheumatoid arthritis in Caucasians (Perdriger et al, 1999) , but Yen et al and Takeuchi et al found no association of the HLA-DM with rheumatoid arthritis in Taiwanese and Japanese populations (Takeuchi et al, 1997; Yen et al, 1997) . West and Reed (1999) reported that the frequencies of DMA n 0103 and DMB n 0102 were increased in patients with juvenile dermatomyositis. Saeki et al (1999) reported that the frequency of DMA n 0102 was increased, and that of DMA n 0101 was decreased, in Japanese psoriasis patients, but no signi¢cant association between DMB alleles and psoriasis was shown. To determine the association between HLA-DM polymorphisms and psoriasis in the Korean population, we investigated the HLA-DM polymorphisms, and found the frequency of DMA n 0102 to be signi¢cantly increased and DMA n 0101/0101 and DMB n 0103/ 0103 to be decreased in psoriasis patients (Table II) . In the analysis of the HLA-DM alleles for the patients divided into types I and II (Table III) , the alleles associated with all psoriasis patients showed signi¢cant di¡erences between the type I psoriasis patients and the controls. Although no signi¢cant di¡erences were found between the type I and type II patients, probably due to the small number of patients in each subgroup, DMA n 0102 was more increased and DMA n 0101/0101 and DMB n 0103/0103 were more decreased in type I compared to type II patients. We also found that these alleles' associations might be independent of the LD with Cw n 0602 ( Table V) .We performed strati¢cation analysis between DMA n 0101/0101 and DMB n 0103/0103 (Table VII) in order to investigate the relationship of the two alleles with psoriasis. The comparison of DMA n 0101/0101 and DMB n 0103/0103 might give results indicating an interaction, although several of the critical p-values were not signi¢cant, which was possibly due to the small numbers in the 2 Â 2 tables. We further analyzed the association between the haplotype of DMA n 0101/0101^DMB n 0103/ 0103 and Cw n 0602, and found that the haplotype association might be independent of Cw n 0602. These data therefore suggest that the associated HLA-DM alleles may be an independent genetic marker of psoriasis to Cw n 0602, especially type I psoriasis patients, and a factor controlled by a certain gene, located between the DMA and DMB, may provide strong protection against psoriasis in the Korean population, independently of Cw n 0602.
In conclusion, we found associations of the TAP and the HLA-DM alleles with psoriasis in our Korean population, suggesting that these alleles could be genetic factors, or markers, of psoriasis. To validate these results, however, additional studies will be required by using an increased sample size and family samples, and investigating the location of the antigen processing genes' region, as well as their functional roles.
